Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
74.31
-1.68 (-2.21%)
Sep 12, 2025, 4:00 PM EDT - Market closed

Mirum Pharmaceuticals Stock Forecast

Stock Price Forecast

The 10 analysts that cover Mirum Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $74.2, which forecasts a -0.15% decrease in the stock price over the next year. The lowest target is $49 and the highest is $89.

Price Target: $74.2 (-0.15%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$49$74.2$80$89
Change-34.06%-0.15%+7.66%+19.77%

Analyst Ratings

The average analyst rating for Mirum Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy455555
Buy777745
Hold000000
Sell000000
Strong Sell000000
Total11121212910

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JP Morgan
JP Morgan
Buy
Maintains
$53$77
BuyMaintains$53$77+3.62%Sep 12, 2025
Stifel
Stifel
Strong Buy
Initiates
$89
Strong BuyInitiates$89+19.77%Aug 11, 2025
Evercore ISI Group
Evercore ISI Group
Buy
Maintains
$77$89
BuyMaintains$77$89+19.77%Aug 8, 2025
JMP Securities
JMP Securities
Buy
Maintains
$79$81
BuyMaintains$79$81+9.00%Aug 7, 2025
Raymond James
Raymond James
Strong Buy
Maintains
$77$82
Strong BuyMaintains$77$82+10.35%Aug 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
515.71M
from 336.89M
Increased by 53.08%
Revenue Next Year
621.19M
from 515.71M
Increased by 20.45%
EPS This Year
-0.79
from -1.85
EPS Next Year
-0.21
from -0.79
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-19.14M77.06M186.37M336.89M515.71M621.19M
Revenue Growth
--302.67%141.85%80.76%53.08%20.45%
EPS
-4.09-2.77-4.02-4.00-1.85-0.79-0.21
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1313
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High546.0M685.7M
Avg515.7M621.2M
Low482.2M554.8M

Revenue Growth

Revenue Growth20252026202720282029
High
62.1%
33.0%
Avg
53.1%
20.5%
Low
43.1%
7.6%

EPS Forecast

EPS20252026202720282029
High-0.361.34
Avg-0.79-0.21
Low-1.13-0.78

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.